v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Sales, net of returns and allowances $ 3,562 $ 750 $ 7,891 $ 1,896
Cost of sales 11,034 2,109 22,845 4,334
Gross loss (7,472) (1,359) (14,954) (2,438)
Operating expenses:        
Selling, general and administrative 7,840 4,469 17,385 8,809
Research and development 4,108 3,197 8,177 6,857
Total operating expenses 11,948 7,666 25,562 15,666
Loss from operations (19,420) (9,025) (40,516) (18,104)
Interest expense, net (800) (3,819) (1,154) (7,395)
Change in fair value of convertible note (132) 0 (277) 0
Change in fair value of stock rights 182 0 1,885 0
Other expense (1) (3) (25) (4)
Loss before benefit for income taxes (20,171) (12,847) (40,087) (25,503)
Benefit for income taxes 0 0 34 0
Net loss $ (20,171) $ (12,847) $ (40,053) $ (25,503)
Net loss per share of common stock - basic (in dollars per share) $ (1.86) $ (1.38) $ (3.84) $ (2.73)
Net loss per share of common stock - diluted (in dollars per share) $ (1.86) $ (1.38) $ (3.84) $ (2.73)
Weighted-average shares used in computing net loss per share of common stock - basic (in shares) 10,854 9,332 10,436 9,331
Weighted-average shares used in computing net loss per share of common stock - diluted (in shares) 10,854 9,332 10,436 9,331